4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137
Key Takeaways
- New York pharmacist licenses are issued by the NYSED Office of the Professions, not by the State Board of Pharmacy, which under Education Law §6804 only "assists the department" in an advisory/investigative role.
- The governing statute is Education Law Article 137 (§§6800-6831); the implementing regulation is Title 8 NYCRR Part 63.
- The State Board of Pharmacy must include at least 9 pharmacists licensed 5+ years, 2 registered pharmacy technicians, and a pharmacist-executive secretary licensed 5+ years, all appointed by the Board of Regents.
- §6801 defines the practice of pharmacy (dispensing, compounding, administering, preserving drugs/devices under prescription or legal authority) plus immunizations, PEP dispensing, and hormonal contraceptive dispensing; §6801-a separately defines collaborative drug therapy management.
- Pharmacy establishment registration ($345 initial, $260 triennial) under §6808 is a separate credential from individual pharmacist licensure under §6805.
Who Regulates Pharmacy in New York
Unlike many states where an independent board issues licenses, pharmacy in New York is regulated by the New York State Education Department (NYSED) through its Office of the Professions (OP). NYSED — not a stand-alone health agency — licenses more than 50 professions statewide, including law, medicine, nursing, and pharmacy, under Title VIII of the Education Law. The New York State Board of Pharmacy exists, but it functions as an advisory and regulatory-assistance body: under Education Law §6804, the Board "assists the department" in regulating pharmacy practice — it does not independently grant or deny licenses. Licensure decisions are made by the Department (acting through OP), under authority delegated by the Board of Regents, which governs NYSED as a whole. For the MPJE, remember the chain: Board of Regents → Commissioner of Education → NYSED/Office of the Professions issues the license; the State Board of Pharmacy advises and investigates.
Governing Law: Education Law Article 137
New York pharmacy practice is governed by Education Law Article 137 (§§6800–6831), one of dozens of profession-specific articles under Title VIII. Article 137 incorporates the general licensing provisions of Article 130 (which apply across every Title VIII profession) and layers on pharmacy-specific rules. Key sections:
| Section | Subject |
|---|---|
| §6800 | Applies Article 130's general provisions to pharmacy |
| §6801 | Definition of the practice of pharmacy |
| §6801-a | Collaborative drug therapy management (CDTM) |
| §6802 | Definitions (30 defined terms, e.g., "drug," "device," "controlled substance") |
| §6803 | Title protection — restricts use of "pharmacist" |
| §6804 | State Board of Pharmacy — composition and duties |
| §6805 | Licensing requirements |
| §6806 | Limited permits (pharmacy interns) |
| §6807 | Exempt persons |
| §6808 | Registration of pharmacy establishments |
| §6809 | Shared pharmacy services |
| §6810 | Prescription requirements |
| §6811 | Misdemeanor violations |
The Commissioner of Education's implementing regulations are codified at Title 8 NYCRR Part 63, which fills in the statute's licensure, internship, and continuing-education mechanics — Part 63 is usually what an MPJE item means by "the regulations," as distinct from "the law" (Article 137 itself).
The State Board of Pharmacy
Education Law §6804 sets the Board's composition at a minimum of nine pharmacists licensed and registered in New York for at least five years, plus two registered pharmacy technicians, and an executive secretary who must also be a pharmacist licensed for at least five years. The Board of Regents appoints all members on the Commissioner's recommendation. The Board's statutory duties include:
- Assisting the Department in regulating the practice of pharmacy, pharmacy technicians, and the employment of interns and pharmacy employees;
- Assisting in regulating the sale and distribution of drugs, poisons, cosmetics, devices, and new drugs;
- Working to prevent the distribution of substandard or misbranded products;
- Investigating alleged violations of the Education Law and Part 63; and
- Issuing limited permits and registrations.
Discipline for individual pharmacists proceeds under the state's general professional-misconduct framework in Education Law §6509 (shared across Title VIII professions), not a pharmacy-only disciplinary statute.
Scope of Practice — §6801
Education Law §6801 defines the "practice of pharmacy" as administering, preparing, compounding, preserving, or dispensing drugs, medicines, and therapeutic devices on the basis of a prescription or other legal authority, and collaborative drug therapy management. The statute has been amended repeatedly to expand pharmacist authority; current §6801 also addresses:
- Administering immunizations and injectable medications under a non-patient-specific order or protocol;
- Dispensing HIV post-exposure prophylaxis (PEP) without a patient-specific prescription in defined circumstances;
- Emergency dispensing of insulin;
- Administering COVID-19 and influenza tests; and
- Dispensing self-administered hormonal contraceptives under a statewide standing order.
Collaborative drug therapy management (CDTM), defined separately in §6801-a, lets a pharmacist perform specified clinical services — such as adjusting drug therapy or ordering labs — under a written agreement with a patient's physician, typically in hospitals and nursing homes. A pharmacist practicing CDTM has additional training obligations and, as covered in section 4.3, an added continuing-education requirement.
Establishment Registration vs. Individual Licensure
Do not confuse the pharmacist license (an individual credential issued under §6805) with pharmacy establishment registration (a business credential under §6808). A pharmacy — the physical location — must separately register with OP; initial establishment registration is $345, with a $260 triennial renewal. Holding a pharmacist license does not, by itself, authorize operating a pharmacy; the establishment itself must be registered, and out-of-state ("nonresident") pharmacies shipping into New York register under §6808-b, which applies the same core standards to mail-order and central-fill operations serving New York patients from another state.
Prescriptions, Shared Services & Enforcement
Article 137 also regulates the mechanics of dispensing and the consequences of violating the law. §6810 governs prescription requirements, including labeling, refill limits, an electronic-prescribing mandate, and generic-substitution protocols. §6809 authorizes shared pharmacy services — arrangements under which multiple pharmacies process, verify, or fill portions of the same prescription (for example, a central-fill facility completing a refill initiated at a retail location) — subject to patient-notification and recordkeeping requirements so a patient always knows which pharmacy is accountable for a given fill. §6808-a requires every pharmacist on duty to wear identification showing their name and title, so patients can distinguish a pharmacist from a technician or intern at the counter.
On the enforcement side, §6811 enumerates roughly 25 Class A misdemeanor violations of Article 137, covering conduct such as practicing without a license, adulterating or misbranding drugs, and failing to maintain required records. These misdemeanor prosecutions run through the ordinary criminal courts and are independent of — and may proceed in parallel with — the Board's administrative investigation and any professional-misconduct discipline imposed by the Department under §6509. A pharmacist can therefore face both a criminal misdemeanor charge and a license suspension arising from the same underlying conduct.
Exam Traps
- The Board of Pharmacy does not issue licenses — NYSED/OP does, with the Board playing an advisory/investigative role under §6804.
- Part 63 is the regulation; Article 137 is the statute. MPJE items may cite either — know which controls for statutory minimums versus regulatory implementation detail.
- Collaborative drug therapy management is defined in §6801-a, a distinct section from the general scope-of-practice definition in §6801.
A pharmacy graduate has satisfied New York's education, examination, and experience requirements and submits a complete license application. Under Education Law §6804, which entity has authority to actually issue the pharmacist license?
Per Education Law §6804, what is the minimum composition of the New York State Board of Pharmacy?
A hospital pharmacist adjusts a patient's warfarin dose and orders an INR lab under a written agreement with the patient's physician. Which Education Law provision authorizes this activity, separate from the general definition of "practice of pharmacy"?
A pharmacist opens a new independent pharmacy in New York. Which of the following is required in addition to the pharmacist's individual license?